Clinical Trial Update: Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating domperidone to treat dopamine agonist-induced peripheral edema in Parkinson's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Domperidone (domperidone)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Parkinson's Disease, Peripheral Edema | Phase 2 | Status: TERMINATED